Company profile for NovMetaPharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

NovMetaPharma is a biopharmaceutical company developing first-in-class therapies targeting metabolic syndromes through novel mechanisms of action. Its drug candidates are based on new molecular entities that activate the AMPK, SIRT1, and Nrf2 pathways?key regulators of metabolic and inflammatory processes. By combining innovative science with an efficient development platform, NovMetaPharma aims to become a global leader in t...
NovMetaPharma is a biopharmaceutical company developing first-in-class therapies targeting metabolic syndromes through novel mechanisms of action. Its drug candidates are based on new molecular entities that activate the AMPK, SIRT1, and Nrf2 pathways?key regulators of metabolic and inflammatory processes. By combining innovative science with an efficient development platform, NovMetaPharma aims to become a global leader in the treatment of metabolic disorders.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Korea
Address
Address
727 Eonju-ro Trees Bldg., 13F, Gangnam-gu,Seoul, 06050
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty